Biodesix to participate in two upcoming investor conferences in november

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading diagnostic solutions company with a focus in lung disease, today announced scott hutton, chief executive officer, will participate in two upcoming investor conferences: canaccord genuity medtech, diagnostics, digital health & services forum presentation and 1x1 meetings presentation date and time: thursday, november 16, 2023 at 3:00 pm et location: westin ny grand central, new york, ny piper sandler 35th annual health.
BDSX Ratings Summary
BDSX Quant Ranking